Myungmoon Pharm (017180) Stock Outlook 2026: Kimite Cash Flow, Generic Pressure, and a Dividend Streak
Myungmoon Pharm (017180) 2026 stock outlook: how Kimite motion-sickness patches and generic prescription drugs fund two straight dividend increases, where small-cap liquidity and price cuts bite, plus a peer table and tax-aware scenarios.